Recent Quarter Total Invested
$7.62 M
Recent Quarter Institutional Ownership Percentage
7.27%
Total Invested of Last Quarter
$12.81 M
Ownership Percentage of Last Quarter
8.97%
Nuvectis Pharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 08/13/2024 | 251,138 | $1.59 M | -15.95% | 1.52% |
BALDWIN BROTHERS LLC/MA | 07/12/2024 | 168,630 | $1.07 M | 9.41% | 1.02% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 119,459 | $756,175 | 202.42% | 0.72% |
BLACKROCK INC. | 08/13/2024 | 83,412 | $527,998 | -77.62% | 0.50% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 74,500 | $471,585 | 20.75% | 0.45% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 61,570 | $389,738 | 100.00% | 0.37% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 53,227 | $336,998 | -60.43% | 0.32% |
NORTHERN TRUST CORP | 08/14/2024 | 49,827 | $315,405 | -19.76% | 0.30% |
GSA CAPITAL PARTNERS LLP | 08/15/2024 | 48,339 | $306,000 | 23.06% | 0.29% |
FORBES J M & CO LLP | 07/30/2024 | 47,419 | $300,162 | 39.47% | 0.29% |
MARSHALL WACE, LLP | 08/14/2024 | 33,868 | $214,384 | -32.36% | 0.20% |
Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 23,173 | $146,685 | 100.00% | 0.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 08/13/2024 | 19,170 | $121,346 | 0.00% | 0.12% |
JANE STREET GROUP, LLC | 08/15/2024 | 17,021 | $107,743 | 100.00% | 0.10% |
STATE STREET CORP | 08/14/2024 | 15,300 | $96,849 | -88.17% | 0.09% |
CITADEL ADVISORS LLC | 08/14/2024 | 14,937 | $94,551 | 100.00% | 0.09% |
JPMORGAN CHASE & CO | 08/12/2024 | 14,753 | $93,386 | 185.63% | 0.09% |
HRT FINANCIAL LP | 08/12/2024 | 13,627 | $86,000 | 100.00% | 0.08% |
CENTIVA CAPITAL, LP | 08/14/2024 | 13,300 | $84,189 | 100.00% | 0.08% |
TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 13,044 | $82,569 | 100.00% | 0.08% |
BAXTER BROS INC | 07/15/2024 | 12,500 | $79,125 | 100.00% | 0.08% |
MORGAN STANLEY | 10/17/2024 | 10,198 | $64,554 | -75.24% | 0.06% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 09/16/2024 | 9,203 | $58,252 | 100.00% | 0.06% |
BARCLAYS PLC | 08/14/2024 | 8,270 | $53,000 | -19.65% | 0.05% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 7,978 | $50,500 | 100.00% | 0.05% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 5,996 | $37,955 | 604.58% | 0.04% |
CITIGROUP INC | 08/12/2024 | 4,883 | $30,909 | 253.33% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 3,254 | $20,598 | 100.00% | 0.02% |
RHUMBLINE ADVISERS | 08/01/2024 | 1,871 | $11,842 | -75.06% | 0.01% |
POINT72 (DIFC) LTD | 09/16/2024 | 1,249 | $7,909 | 100.00% | 0.01% |
FMR LLC | 08/13/2024 | 971 | $6,146 | 123.22% | 0.01% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 764 | $4,836 | -79.76% | 0.00% |
MACQUARIE GROUP LTD | 08/09/2024 | 355 | $2,247 | 100.00% | 0.00% |
NBC SECURITIES, INC. | 07/10/2024 | 300 | $1,000 | 200.00% | 0.00% |
HOLLENCREST CAPITAL MANAGEMENT | 08/13/2024 | 280 | $1,772 | 0.00% | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 07/19/2024 | 212 | $1,342 | 100.00% | 0.00% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/08/2024 | 100 | $633 | 100.00% | 0.00% |
UBS GROUP AG | 08/14/2024 | 13 | $82 | -99.83% | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
LEGAL & GENERAL GROUP PLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 07/31/2024 | 0 | $0 | -100.00% | 0.00% |
STRS OHIO | 08/05/2024 | 0 | $0 | -100.00% | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
AMALGAMATED BANK | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
DEUTSCHE BANK AG\ | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
ROYAL BANK OF CANADA | 11/06/2024 | 0 | $0 | -100.00% | 0.00% |
AMERITAS INVESTMENT PARTNERS, INC. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
TRUST CO OF VERMONT | 07/09/2024 | 0 | $0 | -100.00% | 0.00% |
Nuvectis Pharma, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NVCT shares?
During the previous two years, 36 institutional investors and hedge funds held shares of Nuvectis Pharma, Inc.. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 79,716
MILLENNIUM MANAGEMENT LLC: 68,499
IRIDIAN ASSET MANAGEMENT LLC/CT: 55,380
GSA CAPITAL PARTNERS LLP: 50,129
BlackRock Funding, Inc. /DE: 49,554
FORBES J M & CO LLP: 48,401
-
What percentage of Nuvectis Pharma, Inc. stock is owned by institutional investors?
7.27% of Nuvectis Pharma, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at NVCT ?
Institutional investors have bought a total of 1.17 M shares in the last 24 months. This purchase volume represents approximately $5.77 M in transactions.